298
Views
108
CrossRef citations to date
0
Altmetric
Original Research

Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety

, , , , , , , , , , & show all
Pages 1899-1915 | Published online: 28 Mar 2018

References

  • JacksonSAThomasRMHarrisonSNCross-Sectional Imaging Made Easy2nd edLondonChurchill Livingstone2004
  • ShokrollahiHContrast agents for MRIMater Sci Eng C Mater Biol Appl20133384485449724094150
  • RogosnitzkyMBranchSGadolinium-based contrast agent toxicity: a review of known and proposed mechanismsBiometals201629336537627053146
  • KhawajaAZCassidyDBAl ShakarchiJMcGroganDGInstonNGJonesRGRevisiting the risks of MRI with gadolinium based contrast agents – review of literature and guidelinesInsights Imaging20156555355826253982
  • BarbieriSSchroederCFroehlichJMPaschAThoenyHCHigh signal intensity in dentate nucleus and globus pallidus on unenhanced t1-weighted MR images in three patients with impaired renal function and vascular calcificationContrast Media Mol Imaging201611324525026929131
  • ErranteYCirimeleVMallioCADi LazzaroVZobelBBQuattrocchiCCProgressive increase of t1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelationInvest Radiol2014491068569024872007
  • KandaTIshiiKKawaguchiHKitajimaKTakenakaDHigh signal intensity in the dentate nucleus and globus pallidus on unenhanced t1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast materialRadiology2014270383484124475844
  • European Medicines Agency – Science Medicines HealthEMA/157486/2017. PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorisations Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2017/03/WC500223209.pdfAccessed February 5, 2018
  • RodunerESize matters: why nanomaterials are differentChem Soc Rev200635758359216791330
  • RichardsJMShawCALangNNIn vivo mononuclear cell tracking using superparamagnetic particles of iron oxide: feasibility and safety in humansCirc Cardiovasc Imaging20125450951722787016
  • LiuWFrankJADetection and quantification of magnetically labeled cells by cellular MRIEur J Radiol200970225826418995978
  • DiwokyCLiebmannDNeumayerBPositive contrast of spio-labeled cells by off-resonant reconstruction of 3d radial half-echo bssfpNMR Biomed2015281798825379657
  • HarisinghaniMGBarentszJHahnPFNoninvasive detection of clinically occult lymph-node metastases in prostate cancerN Engl J Med2003348252491249912815134
  • WangYXHussainSMKrestinGPSuperparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imagingEur Radiol200111112319233111702180
  • ChavhanGBBabynPSThomasBShroffMMHaackeEMPrinciples, techniques, and applications of t2*-based MR imaging and its special applicationsRadiographics20092951433144919755604
  • WangYXSuperparamagnetic iron oxide based MRI contrast agents: current status of clinical applicationQuant Imaging Med Surg201111354023256052
  • UnterwegerHJankoCSchwarzMNon-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imagingInt J Nanomedicine2017125223523828769560
  • CullityBDSSRElements of X-Ray DiffractionUpper Saddle River, NJPrentice Hall2001
  • MittemeijerEJWelzelUThe “state of the art” of the diffraction analysis of crystallite size and lattice strainZ Kristallogr20082239552560
  • FrullanoLMeadeTJMultimodal MRI contrast agentsJ Biol Inorg Chem200712793994917659368
  • CichaIBeronovKRamirezELShear stress preconditioning modulates endothelial susceptibility to circulating TNF-alpha and monocytic cell recruitment in a simplified model of arterial bifurcationsAtherosclerosis200920719310219481207
  • LuepkeNPHen’s egg chorioallantoic membrane test for irritation potentialFood Chem Toxicol19852322872914040077
  • SzebeniJBedocsPCsukasDRosivallLBungerRUrbanicsRA porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicinesAdv Drug Deliv Rev201264151706171622820530
  • SwansonHEMcMurdieHFMorrisMCEvansEHPowder Patterns Section 5 Standard X-Ray Diffraction PatternsWashingtonUS Department of Commerce - National Bureau of Standards1967
  • PerfettiGAubertTWildeboerWJMeestersGMHInfluence of handling and storage conditions on morphological and mechanical properties of polymer-coated particles: characterization and modelingPowder Technol20112061–299111
  • SzebeniJComplement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicalsMol Immunol201461216317325124145
  • SzebeniJFishbaneSHedenusMHypersensitivity to intravenous iron: classification, terminology, mechanisms and managementBr J Pharmacol2015172215025503626265306
  • BandaNKMehtaGChaoYMechanisms of complement activation by dextran-coated superparamagnetic iron oxide (spio) nanoworms in mouse versus human serumPart Fibre Toxicol2014116411024382024
  • Carmen BautistaMBomati-MiguelOdel Puerto MoralesMSernaCJVeintemillas-VerdaguerSSurface characterisation of dextran-coated iron oxide nanoparticles prepared by laser pyrolysis and coprecipitationJ Magn Magn Mater200529312027
  • LinMMLiSKimH-HComplete separation of magnetic nanoparticles via chemical cleavage of dextran by ethylenediamine for intracellular uptakeJ Mater Chem2010203444447
  • MorrisMCMcMurdieHFEvansEHParetzkinBParkerHSPanagiotopoulosNCPowder Patterns Section 18 Standard X-Ray Diffraction PatternsWashingtonUS Department of Commerce - National Bureau of Standards1981
  • CornellRMSchwertmannUCrystal Structure The Iron OxidesWeinheimWiley-VCH Verlag, GmbH & Co. KGaA2004938
  • MohapatraSPramanikNGhoshSKPramanikPSynthesis and characterization of ultrafine poly(vinylalcohol phosphate) coated magnetite nanoparticlesJ Nanosci Nanotechnol20066382382916573145
  • Santoyo SalazarJPerezLde AbrilOMagnetic iron oxide nanoparticles in 10–40 nm range: composition in terms of magnetite/ maghemite ratio and effect on the magnetic propertiesChem Mater201123613791386
  • LangfordJICernikRJLouerDThe breadth and shape of instrumental line profiles in high-resolution powder diffractionJ Appl Crystallogr1991245913919
  • LassenbergerAScheberlAStadlbauerAStiglbauerAHelbichTReimhultEIndividually stabilized, superparamagnetic nanoparticles with controlled shell and size leading to exceptional stealth properties and high relaxivitiesACS Appl Mater Interfaces2017943343335328071883
  • VismaraEBongioCColettiAAlbumin and hyaluronic acid-coated superparamagnetic iron oxide nanoparticles loaded with paclitaxel for biomedical applicationsMolecules2017227E103028640222
  • KhalkhaliMSadighianSRostamizadehKSynthesis and characterization of dextran coated magnetite nanoparticles for diagnostics and therapyBioimpacts20155314115026457252
  • TóthIYIllésEBauerRADesigned polyelectrolyte shell on magnetite nanocore for dilution-resistant biocompatible magnetic fluidsLangmuir20122848166381664623140279
  • ZalogaJJankoCAgarwalRDifferent storage conditions influence biocompatibility and physicochemical properties of iron oxide nanoparticlesInt J Mol Sci20151659368938425918940
  • OberleALüdtke-BuzugKStability analysis of superparamagnetic iron oxide nanoparticles at 37°CBiomed Tech (Berl)2013812
  • WangGChenFBandaNKActivation of human complement system by dextran-coated iron oxide nanoparticles is not affected by dextran/fe ratio, hydroxyl modifications, and crosslinkingFront Immunol2016741827777575
  • SmitsLPCoolenBFPannoMDNoninvasive differentiation between hepatic steatosis and steatohepatitis with MR imaging enhanced with uspios in patients with nonalcoholic fatty liver disease: a proof-of-concept studyRadiology2016278378279126348104
  • JungCWSurface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsilMagn Reson Imaging19951356756918569442
  • SimbergDParkJHKarmaliPPDifferential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearanceBiomaterials20093023–243926393319394687
  • ChaoYMakaleMKarmaliPPRecognition of dextran-super-paramagnetic iron oxide nanoparticle conjugates (feridex) via macrophage scavenger receptor charged domainsBioconjug Chem20122351003100922515422
  • WibroePPAnselmoACNilssonPHBypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytesNat Nanotechnol201712658959428396605
  • LevyJHAnaphylactic Reactions in Anesthesia and Intensive CareOxfordElsevier Science2013
  • VidemVMollnesTEHuman complement activation by polygeline and dextran 70Scand J Immunol19943933143207510416
  • WangGInturiSSerkovaNJHigh-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating propertiesACS Nano2014812124371244925419856